Funded Biotechnology Startups in New York
Definium Therapeutics’ $805M round (2026-06-23) is a clear size outlier in this New York biotechnology list, dwarfing the next-largest disclosed rounds at…
Definium Therapeutics’ $805M round (2026-06-23) is a clear size outlier in this New York biotechnology list, dwarfing the next-largest disclosed rounds at $533M (Renaissance Philanthropy, 2026-05-06) and $400M (Immunic Therapeutics, 2026-02-13). The disclosed amounts also show a long tail: the smallest disclosed round is $40K (BioVaxys, 2025-04-01), while multiple entries cluster around $250M (Nuvation Bio on 2026-06-25; TG Therapeutics on 2024-08-06). Temporally, the 50 most recent rounds span 2024-08-06 to 2026-07-20, with the newest set concentrated in mid-2026 (e.g., Reme-D on 2026-07-20; multiple June 2026 events including Nuvation Bio at $250M and Definium at $805M). Geographic concentration is extreme: all entries list New York as the city, with New York, New York appearing for every company. Stage disclosures are also mixed in classification labels (including many “Series Unknown” rounds such as Immunic Therapeutics’ $400M on 2026-02-13 and Nuvation Bio’s $250M on 2026-06-25), alongside clearly labeled rounds like Series A (e.g., Waypoint Bio, $20M on 2026-05-27) and Seed (e.g., Reme-D, $1M on 2026-07-20).
Most recent rounds
50 of 12676 more funded startups
This page shows the 50 most recent rounds (back to Aug 2024). The full 126-company history for this listing is available on a paid plan.
Unlock all 126 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which disclosed round is the largest in this New York biotech list, and how far above the rest is it?
Definium Therapeutics’ disclosed $805M (2026-06-23) is the largest; it sits above Renaissance Philanthropy’s $533M (2026-05-06) and Immunic Therapeutics’ $400M (2026-02-13). The remaining top disclosed entries include $250M levels (Nuvation Bio on 2026-06-25 and TG Therapeutics on 2024-08-06).
Do the biggest rounds cluster in a narrow time window, or are they spread out across the period?
Several of the largest disclosed rounds land in 2024–2026’s upper range, including Definium at $805M (2026-06-23) and Renaissance Philanthropy at $533M (2026-05-06), plus large rounds in 2024 such as TG Therapeutics’ $250M (2024-08-06) and Metsera’s $215M (2024-11-13). That said, large and small rounds both occur across the full span from 2024-08-06 to 2026-07-20, with the smallest disclosed amount at BioVaxys ($40K) on 2025-04-01.
Are any companies’ disclosed sizes notably closer to the floor than the rest, making the distribution skewed?
Yes. The lowest disclosed amount is $40K for BioVaxys (2025-04-01), while the top disclosed rounds run from $160M (Relmada Therapeutics, 2026-03-09) up to $805M (Definium Therapeutics, 2026-06-23). This creates a pronounced gap between the smallest disclosed events and the upper tier of disclosed financing.
Which classification label appears most often in this dataset, based on the presence of many “Series Unknown” entries?
“Series Unknown” is a dominant label across disclosed and undisclosed outcomes—for example, Nuvation Bio’s $250M (2026-06-25) and Immunic Therapeutics’ $400M (2026-02-13) are both marked “Series Unknown.” There are also labeled rounds such as Series A (Waypoint Bio at $20M on 2026-05-27; Gilgamesh Pharmaceuticals at $60M on 2026-03-24) and Seed (Reme-D at $1M on 2026-07-20; BioSapien at $6M on 2024-12-13).
Which city/geography pattern stands out across entries, and does any different geography appear?
Geography is effectively single-city in this listing: the city field is New York for all entries, and New York, New York appears repeatedly (every company in the provided rows shows “New York, New York, United States” or “New York, United States” with no other city listed). This makes geographic variation an outlier rather than the norm in the dataset.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.